Tanzi Elizabeth L, Perez Maritza
St. Lukes-Roosevelt Department of Dermatology, New York, New York 10019, USA.
Dermatol Surg. 2002 Apr;28(4):305-8. doi: 10.1046/j.1524-4725.2002.01130.x.
There are several types of dressings which may be utilized after facial laser resurfacing. Laser surgeons favoring the open type of dressing have used the Aquaphor original formula to reduce the loss of moisture from laser resurfaced skin. The objective of this study was to compare the effectiveness of a mucopolysaccharide-cartilage complex (MCC) containing healing ointment with the standard therapy of Aquaphor ointment in treating erythema, edema, and skin erosion caused by Er:YAG laser resurfacing of facial skin.
To compare healing time after Er:YAG laser resurfacing treated side-by-side with MCC as compared with Aquaphor.
Nineteen patients completing Er:YAG laser resurfacing were randomly assigned to receive MCC healing ointment on one side of their face and standard therapy with Aquaphor on the other for eight consecutive treatment days. Immediately after surgery and again on days 1, 2, 3, 4, 7, and 8, the severity of erythema, edema, and erosion was scored on a 0-3 scale (0 = no observable effect, 1 = mild, 2 = moderate, 3 = severe). Photographs were taken at each follow-up visit. Following scoring on study day 0, the day of resurfacing, treatment was applied according to the left or right assignment code of the randomization schedule.
Mean severity ratings for all variables (erythema, edema, and erosion) were consistently lower for MCC healing ointment as compared to Aquaphor ointment. Based on the calculated overall efficacy index, MCC ointment was statistically superior to Aquaphor for all three variables: erythema, P <.001; edema, P =.017; erosion, P <.001.
The results of our study demonstrate that MCC healing ointment may provide an advantage over the standard therapy of Aquaphor ointment in the treatment of edema, erosion, and erythema caused by laser resurfacing of facial skin. Mean daily severity scores were consistently lower and improvement tended to occur earlier with MCC healing ointment.
面部激光换肤术后可使用多种类型的敷料。支持开放式敷料的激光外科医生使用优色林原配方产品来减少激光换肤皮肤的水分流失。本研究的目的是比较含黏多糖 - 软骨复合物(MCC)的愈合软膏与优色林软膏标准疗法在治疗铒激光面部皮肤换肤引起的红斑、水肿和皮肤糜烂方面的有效性。
比较铒激光换肤后使用MCC与使用优色林并排治疗的愈合时间。
19名完成铒激光换肤的患者被随机分配,在其面部一侧连续8天接受MCC愈合软膏治疗,另一侧接受优色林标准疗法治疗。术后立即以及在第1、2、3、4、7和8天,红斑、水肿和糜烂的严重程度按0 - 3级评分(0 = 无明显影响,1 = 轻度,2 = 中度,3 = 重度)。每次随访时拍照。在研究第0天(换肤日)评分后,根据随机分组时间表的左右分配代码进行治疗。
与优色林软膏相比,MCC愈合软膏的所有变量(红斑、水肿和糜烂)的平均严重程度评分始终较低。根据计算出的总体疗效指数,MCC软膏在所有三个变量上在统计学上均优于优色林:红斑,P <.001;水肿,P =.017;糜烂,P <.001。
我们的研究结果表明,MCC愈合软膏在治疗面部皮肤激光换肤引起的水肿、糜烂和红斑方面可能优于优色林软膏标准疗法。MCC愈合软膏的平均每日严重程度评分始终较低,且改善往往更早出现。